Orgenesis to Present at the Summer Solstice Conference - Best Ideas from the Buy-Side on June 2nd

Rhea-AI Summary

Orgenesis, a global biotech company focused on cell and gene therapies, announced its participation in the Summer Solstice Conference hosted by The MicroCap Rodeo, from June 1-4, 2021. CEO Vered Caplan will present on June 2 at 2:30 PM Eastern Time and engage in one-on-one meetings with investors. The conference showcases the top 25 companies recommended as best ideas by qualified institutional investors. Interested parties can access the presentation live or on replay through the provided link.

GERMANTOWN, Md., June 01, 2021 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies, today announced that it will be presenting at the Summer Solstice Conference, hosted by The MicroCap Rodeo, being held virtually on June 1^st – June 4^th, 2021.

Vered Caplan, CEO of Orgenesis is scheduled to present on Wednesday, June 2nd, 2021 at 2:30 PM, Eastern Time and will participate in one-on-one meetings with investors and analysts throughout the conference.

The presentation will be webcast live and available for replay at https://www.webcaster4.com/Webcast/Page/2134/41525.

To receive additional information about the conference, request an invitation, or to schedule a one-on-one meeting with Orgenesis, please email angie.goertz@issuerdirect.com.

About the Summer Solstice Conference
The MicroCap Rodeo is hosting its “Summer Solstice Conference-Best Ideas Bowl”, with 25-minute virtual presentations and one-on-ones for qualified institutional investors. This conference is a virtual conference that brings you the top 25 best ideas from the buy side. Qualified institutional investors recommended each of the 25 companies represented as one of their best ideas. For more information, please visit the event website: https://microcaprodeo.com/.

About Orgenesis
Orgenesis is a global biotech company working to unlock the full potential of cell and gene therapies (CGTs) in an affordable and accessible format at the point of care. The Orgenesis POCare Platform is comprised of three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. Orgenesis identifies promising new therapies and leverages its POCare Platform to provide a rapid, globally harmonized pathway for these therapies to reach and treat large numbers of patients at lowered costs through efficient, scalable, and decentralized production. The POCare Network brings together patients, doctors, industry partners, research institutes and hospitals worldwide to achieve harmonized, regulated clinical development and production of the therapies. Learn more about the work Orgenesis is doing at www.orgenesis.com.

Contact for Orgenesis:
David Waldman
Crescendo Communications, LLC
Tel: 212-671-1021

FAQ

When will Orgenesis present at the Summer Solstice Conference 2021?

Orgenesis is scheduled to present on June 2, 2021, at 2:30 PM Eastern Time.

What is the Summer Solstice Conference hosted by The MicroCap Rodeo?

The Summer Solstice Conference is a virtual event featuring top companies recommended by qualified institutional investors, offering presentations and one-on-one meetings.

How can I watch the Orgenesis presentation at the Summer Solstice Conference?

The presentation will be webcast live and available for replay via the link provided in the press release.

What is the focus of Orgenesis as a biotech company?

Orgenesis focuses on cell and gene therapies, providing innovative and affordable treatments through its POCare Platform.

What is the ticker symbol for Orgenesis?

The ticker symbol for Orgenesis is ORGS.